China SXT Pharmaceuticals, Inc. (SXTC) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
China SXT Pharmaceuticals, Inc. (SXTC) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $1.3M, listed on NASDAQ, employing roughly 75 people, carrying a beta of 1.96 to the broader market. China SXT Pharmaceuticals, Inc. Led by Feng Zhou, public since 2019-01-04.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for SXTC as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.